Eur Rev Med Pharmacol Sci 2018; 22 (5): 1178-1179
DOI: 10.26355/eurrev_201803_14455

Formyl peptide receptor 2 mediated chemotherapeutics drug resistance in colon cancer cells. Point of view from pharmacogenetics field

G. Marotta, T. Muto, G. Benincasa, A. De Monaco

Institute for Study and Care of Diabetes (ISCD), Genetic Service, “Abetaia” Casagiove, Caserta, Italy. angelademonaco@yahoo.it

Free PDF Download

To cite this article

G. Marotta, T. Muto, G. Benincasa, A. De Monaco
Formyl peptide receptor 2 mediated chemotherapeutics drug resistance in colon cancer cells. Point of view from pharmacogenetics field

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 5
Pages: 1178-1179
DOI: 10.26355/eurrev_201803_14455

Keywords Related articles:

  1. Formyl peptide receptor 2 mediated chemotherapeutics drug resistance in colon cancer cells
  2. Comment on: “Formyl peptide receptor 2 mediated chemo-therapeutics drug resistance in colon cancer cells”
  3. Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view
  4. Targeting colon cancer stem cells with novel blood cholesterol drug pitavastatin
  5. MiR-183 modulates multi-drug resistance in hepatocellular cancer (HCC) cells via miR-183-IDH2/SOCS6-HIF-1α feedback loop